Clinical Trials
12
Active:2
Completed:5
Trial Phases
2 Phases
Phase 1:11
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (91.7%)Phase 3
1 (8.3%)Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Insomnia Characterized
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06890715
- Locations
- 🇨🇳
clinical trial centre of Medical ethics committee of Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-10
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06589921
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-09
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06588517
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT06569381
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.
Phase 1
Not yet recruiting
- Conditions
- Epilepsy
- Interventions
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05788159
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
- Prev
- 1
- 2
- 3
- Next
News
No news found